Table:
Classification	Mesothelin (nmol/L)Median (min-max)	Midkine (pg/mL)Median (min-max)
Stage (case number)a
I (12)	0.95 (0.30-67.50)	220.54 (103.95-5508.08)
II (11)	1.20 (0.30-2.80)	513.61 (103.95-2143.51)
III (34)	1.25 (0.40-21.50)	644.89 (103.95-17,381.64)
IV (36)	2.90 (0.30-27.40)	925.17 (103.95-5244.74)
p = 0.052	p = 0.059
Histology (case number)
Epitheloid (66)	2.00 (0.30-67.50)	623.56 (103.95-17,381.64)
Non-epitheloid (23)	1.20 (0.30-9.0)	753.50(103.95-5244.74)
Undefined (6)b	1.25 (0.60-7.40)	768.13 (103.95-1722.46)
p = 0.033	p = 0.501
Chemotherapy response (case number)
Progressive disease (16)	1.75 (0.30-67.50)	731.47 (103.95-5508.08)
Stable disease (17)	1.70 (0.40-7.70)	417.94 (103.95-2832.48)
Objective response (12)	2.70 (0.70-21.50)	441.06 (103.95-17,381.64)
p = 0.452	p = 0.669

Continue parse the illustration with markdown style: | Classification | Mesothelin (nmol/L)Median (min-max) | Midkine (pg/mL)Median (min-max) | 
 | --- | --- | --- | 
 | <COLSPAN=3> Stage (case number)a | 
 | I (12) | 0.95 (0.30-67.50) | 220.54 (103.95-5508.08) | 
 | II (11) | 1.20 (0.30-2.80) | 513.61 (103.95-2143.51) | 
 | III (34) | 1.25 (0.40-21.50) | 644.89 (103.95-17,381.64) | 
 | IV (36) | 2.90 (0.30-27.40) | 925.17 (103.95-5244.74) | 
 |  | p = 0.052 | p = 0.059 | 
 | <COLSPAN=3> Histology (case number) | 
 | Epitheloid (66) |

2.00 (0.30-67.50) | 623.56 (103.95-17,381.64) | 
 | Non-epitheloid (23) | 1.20 (0.30-9.0) | 753.50(103.95-5244.74) | 
 | Undefined (6)b | 1.25 (0.60-7.40) | 768.13 (103.95-1722.46) | 
 |  | p = 0.033 | p = 0.501 | 
 | <COLSPAN=3> Chemotherapy response (case number) | 
 | Progressive disease (16) | 1.75 (0.30-67.50) | 731.47 (103.95-5508.08) | 
 | Stable disease (17) | 1.70 (0.40-7.70) | 417.94 (103.95-2832.48) | 
 | Objective response (12) | 2.70 (0.70-21.50) | 441.06 (103.95-17,381.64) | 
 |  | p = 0.452 | p = 0.669 |